Home › Incyte Announces Top-Line Results From RELIEF Trial Of Ruxolitinib In Patients With Polycythemia Vera
 

Keywords :   


Incyte Announces Top-Line Results From RELIEF Trial Of Ruxolitinib In Patients With Polycythemia Vera

2014-07-30 09:39:10| drugdiscoveryonline Home Page

Incyte Corporation recently announced top-line results from RELIEF, a randomized, double-blind clinical trial designed to compare symptom improvement in 110 patients with polycythemia vera (PV) treated with ruxolitinib versus patients treated with hydroxyurea (HU)

Tags: with results trial patients

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.11171
15.11 3FLYOVER
15.11 PSA8 - 1ed
15.11DMC RAVEN 18g
15.11LOVE or DEAD Blu-ray
15.11 HSGI SURE-GRIP PADDED BELT a-tacs au
15.11 BOUNTY HUNTER
15.11
More »